Clinical Trials List
Protocol NumberLOXO-BTK-20020 (J2N-OX-JZNN)
Completed
2021-07-30 - 2025-12-31
Phase III
Recruiting1
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳嘉紘 Division of Radiology
- 陳玟均 Division of Hematology & Oncology
- 蔡淳光 Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- Po-Shen Ko Division of Hematology & Oncology
- Ting-An Lin Division of Hematology & Oncology
- Chia-Jen Liu Division of Hematology & Oncology
- Sheng-Hsuan Chien Division of Hematology & Oncology
- 李函叡 Division of Radiology
- 陳蓉宣 Division of Radiology
- Liang-Tsai Hsiao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
250 participants
